Nov 02, 2017 8:05am EDT Second Sight Receives Full FDA Approval to Begin First Orion Human Clinical Study
Nov 02, 2017 8:00am EDT Second Sight Announces Final Medicare Hospital Outpatient Payment Rate for 2018 for the Argus II Retinal Prosthesis System
Oct 26, 2017 8:00am EDT Second Sight to Discuss Third Quarter 2017 Financial Results on November 2, 2017 Conference Call
Oct 19, 2017 7:00am EDT Second Sight Announces Appointments of Frank Vandeputte as Vice President and General Manager, EMEA and Asia Pacific; Gregoire Cosendai as Vice President, Clinical Affairs
Oct 17, 2017 7:00am EDT Second Sight Receives Approval from Bundesinstitut für Arzneimittel und Medizinprodukte in Germany to Begin Study to Implant and Evaluate Argus II in Better-Sighted Retinitis Pigmentosa Patients
Sep 05, 2017 8:00am EDT Second Sight to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York on September 12th
Aug 28, 2017 8:00am EDT Second Sight Receives Conditional FDA Approval to Begin First Orion Human Clinical Study
Jul 26, 2017 8:30am EDT Second Sight Announces Market Entry into Russia with First Implant of Argus II Retinal Prosthesis System
Jul 20, 2017 4:30pm EDT Second Sight to Discuss Second Quarter 2017 Financial Results on August 1, 2017 Conference Call